SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Romano, who is based in the United States, brings over two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company's financial operations as it advances its global expansion strategy, including the pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Romano most recently served as CFO of Vicarious Surgical, where she led initiatives to reduce cash burn, strengthen the balance sheet, and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting, and investor relations. Her experience in capital markets and financial stewardship is expected to be instrumental as SS Innovations scales its operations.
SS Innovations develops innovative surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support various procedures including cardiac surgery. The company, headquartered in India, plans to expand the global presence of its cost-effective solutions. The appointment of Romano signals a strategic move to strengthen financial leadership ahead of key regulatory milestones.
For more details, visit the full press release at https://ibn.fm/pAqlP.
About SS Innovations: SS Innovations International, Inc. (NASDAQ: SSII) is an American company headquartered in India that develops surgical robotic technologies. The company's mission is to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. For the latest news and updates, visit the company's newsroom at https://ibn.fm/SSII.
This appointment comes at a critical time as SS Innovations seeks FDA approval for its SSi Mantra system, which could position the company to compete with established players in the robotic surgery market. Romano's track record in raising capital and managing financial operations will be key to supporting the company's growth ambitions.
